Percheron Therapeutics(DE:AWY0)
€0.03+0.00 (+3.23%)
DE:AWY0
Percheron Therapeutics financials statements
€0.03
At close:+0.00 (+3.23%)
Percheron Therapeutics (AWY0) Financial Statements
0 Followers
Percheron Therapeutics Financial Overview
Percheron Therapeutics's market cap is currently AU$3.67M. The company's EPS TTM is AU$-0.00; its P/E ratio is -0.73; Percheron Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 |
| Gross Profit | AU$ -219.56K | AU$ -67.98K | AU$ -79.42K | AU$ -95.20K | AU$ -89.22K |
| Operating Income | AU$ -5.62M | AU$ -16.71M | AU$ -14.88M | AU$ -13.34M | AU$ -7.61M |
| EBITDA | AU$ -5.40M | AU$ -16.27M | AU$ -11.84M | AU$ -13.25M | AU$ -7.52M |
| Net Income | AU$ -4.79M | AU$ -14.92M | AU$ -11.92M | AU$ -11.38M | AU$ -5.81M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 4.05M | AU$ 10.17M | AU$ 11.87M | AU$ 10.97M | AU$ 19.23M |
| Total Assets | AU$ 8.22M | AU$ 12.44M | AU$ 14.53M | AU$ 12.84M | AU$ 22.44M |
| Total Debt | AU$ 27.79K | AU$ 25.86K | AU$ 39.87K | AU$ 142.10K | AU$ 227.40K |
| Net Debt | AU$ -2.52M | AU$ -10.14M | AU$ -11.83M | AU$ -10.83M | AU$ -19.01M |
| Total Liabilities | AU$ 692.18K | AU$ 2.43M | AU$ 5.17M | AU$ 2.87M | AU$ 1.30M |
| Stockholders' Equity | AU$ 7.53M | AU$ 10.00M | AU$ 9.36M | AU$ 9.98M | AU$ 21.14M |
| Cash Flow | |||||
| Free Cash Flow | AU$ -4.97M | AU$ -15.65M | AU$ -10.12M | AU$ -8.18M | AU$ -7.81M |
| Operating Cash Flow | AU$ -4.96M | AU$ -15.64M | AU$ -10.12M | AU$ -8.15M | AU$ -7.81M |
| Investing Cash Flow | AU$ -3.09M | AU$ -7.24K | AU$ -3.61K | AU$ -29.29K | AU$ -3.91K |
| Financing Cash Flow | AU$ 1.93M | AU$ 13.95M | AU$ 11.02M | AU$ -85.30K | AU$ 21.02M |
Currency in AUD
